Natriuretic peptide biomarkers as information indicators in elderly patients with possible heart failure followed over six years: a head-to-head comparison of four cardiac natriuretic peptides.

BACKGROUND Little is known about the differences between natriuretic peptides used to evaluate elderly patients with heart failure. The aim of the study was to evaluate the information and the power to predict cardiovascular mortality derived from an analysis of cardiac natriuretic peptides from the same study population and at the same time. METHODS AND RESULTS In all, 415 elderly patients (age 65-82 years) in primary health care were evaluated and followed for 6 years. All patients had symptoms of heart failure and were examined by a cardiologist. An electrocardiogram and chest x-rays were taken, and the systolic and diastolic functions were assessed using Doppler echocardiography. Brain natriuretic peptide (BNP), N-terminal proBNP, atrial natriuretic peptide (ANP), and N-terminal proANP were analyzed. All 4 peptides were associated with age, and only 1 of them showed any gender difference. Three of the 4 peptides (not ANP) provided important information for identifying patients with impaired systolic function and diastolic dysfunction (pseudonormal or restrictive filling pattern), and for assessing the risk of cardiovascular death. CONCLUSIONS Cardiac natriuretic peptides are useful tools for evaluating elderly patients with heart failure. Three of the 4 peptides were very similar. ANP exhibits inferior properties and cannot be recommended in clinical practice.

[1]  F. Boomsma,et al.  Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. , 2001, Cardiovascular research.

[2]  P. Hildebrandt,et al.  Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations , 2001, European journal of heart failure.

[3]  M. Emdin,et al.  Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. , 2004, Clinical chemistry.

[4]  K. Kugiyama,et al.  Localization and Mechanism of Secretion of B‐Type Natriuretic Peptide in Comparison With Those of A‐Type Natriuretic Peptide in Normal Subjects and Patients With Heart Failure , 1994, Circulation.

[5]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[6]  Karl G. Jöreskog,et al.  Lisrel 8: Structural Equation Modeling With the Simplis Command Language , 1993 .

[7]  C. Frampton,et al.  B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial Infarction , 2003, Circulation.

[8]  N. Ahmadi,et al.  Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma , 2001, Scandinavian journal of clinical and laboratory investigation.

[9]  D E Grobbee,et al.  The epidemiology of heart failure. , 1997, European heart journal.

[10]  T. Omland,et al.  Plasma cardiac natriuretic peptide determination as a screening test for the detection of patients with mild left ventricular impairment. , 1996, Heart.

[11]  H. Tunstall-Pedoe,et al.  Biochemical detection of left-ventricular systolic dysfunction , 1998, The Lancet.

[12]  D. J. Veldhuisen,et al.  Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT‐ANP and BNP/NT‐proBNP , 2005, European journal of heart failure.

[13]  M. Jensen-Urstad,et al.  Comparison of different echocardiographic methods with radionuclide imaging for measuring left ventricular ejection fraction during acute myocardial infarction treated by thrombolytic therapy. , 1998, The American journal of cardiology.

[14]  L. Levin,et al.  Risk of cardiovascular death in elderly patients with possible heart failure. B-type natriuretic peptide (BNP) and the aminoterminal fragment of ProBNP (N-terminal proBNP) as prognostic indicators in a 6-year follow-up of a primary care population. , 2005, International journal of cardiology.

[15]  Forrest W. Young,et al.  Introduction to Multidimensional Scaling: Theory, Methods, and Applications , 1981 .

[16]  K. Nakao,et al.  Brain natriuretic peptide in an elderly population , 1997, Journal of internal medicine.

[17]  P. Hildebrandt,et al.  The influence of age, sex and other variables on the plasma level of N-terminal pro brain natriuretic peptide in a large sample of the general population , 2003, Heart.

[18]  E. Nylander,et al.  Heart Failure in the Elderly: Characteristics of a Swedish Primary Health Care Population , 2002, Heart Drug.

[19]  A. D. de Bold,et al.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.

[20]  J. Sundsfjord,et al.  Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. , 1988, The Journal of clinical endocrinology and metabolism.

[21]  J. Karl,et al.  Development of a novel, N-terminal-proBNP (NT-proBNP) assay with a low detection limit. , 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[22]  R. Berger,et al.  Incidence of normal values of natriuretic peptides in patients with chronic heart failure and impact on survival: A direct comparison of N‐terminal atrial natriuretic peptide, N‐terminal brain natriuretic peptide and brain natriuretic peptide , 2005, European journal of heart failure.

[23]  J. Cohn,et al.  Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. , 2006, Clinical chemistry.

[24]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[25]  M. Uschold,et al.  Methods and applications , 1953 .

[26]  Y. Doi,et al.  Heart failure in the elderly. , 2003, Internal medicine.

[27]  J. Mair,et al.  Head-to-head comparison of N-terminal pro-brain natriuretic peptide, brain natriuretic peptide and N-terminal pro-atrial natriuretic peptide in diagnosing left ventricular dysfunction. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[28]  M. Emdin,et al.  The Circulating Levels of Cardiac Natriuretic Hormones in Healthy Adults: Effects of Age and Sex , 2002, Clinical chemistry and laboratory medicine.